PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Identifies how quickly the company is scaling its balance sheet (via acquisitions, expansions, or debt). Strong growth, accompanied by sound fundamentals, can support long-term intrinsic value—while disproportionate debt expansion or bloated intangible assets can signal elevated risk.
-8.57%
Both companies show declining cash positions (-8.57% vs AVXL's -0.45%). Seth Klarman would examine if this reflects broader market conditions or operational challenges.
No Data
No Data available this quarter, please select a different quarter.
-8.57%
Cash + STI yoy ≥ 1.5x AVXL's -0.45%. David Dodd might see it as a strategic cash buffer advantage. Evaluate deployment plans.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-16.59%
Similar to AVXL's -21.26%. Walter Schloss would confirm standard short-term asset patterns.
-8.67%
≥ 1.5x AVXL's -2.06%. David Dodd might see a short-term liquidity advantage or potential underutilized capital.
-8.20%
Both AVXL and the company show zero PP&E (Net) Growth.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
1.26%
Higher Other Non-Current Assets Growth compared to AVXL's zero value, indicating worse performance.
-7.12%
Below half of AVXL's -100.00%. Michael Burry might suspect stagnation or lack of resources for expansions.
No Data
No Data available this quarter, please select a different quarter.
-8.62%
≥ 1.5x AVXL's -2.22%. David Dodd notes a larger balance sheet expansion. Confirm it's not overleveraged.
-100.00%
Above 1.5x AVXL's -5.98%. Michael Burry questions if payables are being stretched to avoid short-term borrowing.
-100.00%
Higher Short-Term Debt Growth compared to AVXL's zero value, indicating worse performance.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
1405.81%
Exceeding 1.5x AVXL's 12.32%. Michael Burry suspects ballooning short-term obligations vs. competitor.
-20.28%
Less than half of AVXL's 22.98%. David Dodd sees a more disciplined short-term liability approach.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-0.40%
Less than half of AVXL's -100.00%. David Dodd sees a more conservative approach to non-current liabilities.
No Data
No Data available this quarter, please select a different quarter.
-4.61%
Less than half of AVXL's 22.98%. David Dodd sees far fewer liability expansions relative to competitor.
No Data
No Data available this quarter, please select a different quarter.
-3.23%
0.75-0.9x AVXL's -3.91%. Bill Ackman questions if competitor reinvests profits more robustly.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-12.84%
≥ 1.5x AVXL's -4.00%. David Dodd sees stronger capital base growth than competitor.
-8.62%
≥ 1.5x AVXL's -2.22%. David Dodd sees faster overall balance sheet growth than competitor.
-100.00%
≥ 1.5x AVXL's -61.97%. David Dodd sees far stronger investment expansions than competitor.
-7.46%
Higher Total Debt Growth compared to AVXL's zero value, indicating worse performance.
8.60%
Above 1.5x AVXL's 0.45%. Michael Burry sees a major gap in net debt growth. Check coverage and liquidity.